So in 2014, the FDA began approving these medications for weight loss first Saxenda (liraglutide) , then Wegovy (semaglutide) , Zepbound (tirzepatide) , and most recently, Foundayo (orforglipron)
Dipeptidyl peptidase-4 (DPP-4): Localization and activity in human and rodent islets
Linzess and alcohol can increase the risk of headache, dehydration, and diarrhea
Currently, 25% of adults in the United Kingdom are living with obesity and the rise in obesity has significantly increased the number of patients with T2DM [4,5,6]
It appears to work through multiple mechanisms: growth factors, nitric oxide, inflammation, and more
Research has shown reduced melanin levels compared to placebo groups, though results vary based on metabolism, dosage, and absorption